Practice Advances: A focus on neffy® (epinephrine nasal spray)February 16th 2026ARS Pharmaceuticals presents real-world data at the ACAAI Annual Scientific Meeting in November 2025.
A Look at Lynkuet® (Elinzanetant) for the Treatment of Moderate to Severe Vasomotor SymptomsNovember 5th 2025
